2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the
about
Treating arrhythmias with adjunctive magnesium: identifying future research directionsDifferent impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trialExternal prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR-Flash study.Left ventricular dysfunction is associated with frequent premature ventricular complexes and asymptomatic ventricular tachycardia in children.Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres.Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.Wearable cardioverter defibrillator: Bridge or alternative to implantation?Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysisComparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated CardiomyopathyNatural and Undetermined Sudden Death: Value of Post-Mortem Genetic InvestigationInappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis.Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac DeathPart 4. Post-cardiac arrest care: 2015 Korean Guidelines for Cardiopulmonary Resuscitation.Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic CardiomyopathyLeft-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction.Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial.Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.Incidence of arrhythmias in a large cohort of patients with current implantable cardioverter-defibrillators in Spain: results from the UMBRELLA Registry.The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey.Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.Imaging for assessment of sudden death risk: current role and future prospects.Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.The clinical value of T-wave alternans derived from Holter monitoring.Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.Influence of patients' age at implantation on mortality and defibrillator shocks.Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment.Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey.Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience.Sudden cardiac death in patients with rheumatoid arthritisSudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies.New Task Force Criteria Provide Evolution in Diagnosis of Arrhythmogenic Cardiomyopathy in Patients without Typical Progression of the Disease3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology.Cardiac magnetic resonance imaging: Which information is useful for the arrhythmologist?Subcutaneous defibrillator implantation as a bridge until left ventricular function normalizes.Genetic testing for exercise prescription and injury prevention: AIS-Athlome consortium-FIMS joint statement.
P2860
Q28078430-0803C3BB-E845-4E77-A720-0DCB0995C9C1Q31119225-2C80149E-0C0A-414D-AC57-B57C4CA8DA45Q33166397-E08C9A19-88A2-44EA-9D97-EFDE16FCFF30Q33168548-B43DF0E4-664E-412B-BBDD-837CA28008CFQ33603090-C3FC3A42-2D42-4598-98A1-5A9EB2F9E0D1Q33770849-D8F6ADB8-4062-4C55-AEE2-B9441104802EQ33854130-04EE0D95-5659-4CED-9BA5-32F08621D35AQ35922869-C0AA574D-5439-4910-B851-3777F7FB857FQ36216050-911D00C2-CDC2-45F3-9036-1444A43EAE7BQ36216129-448814B5-46F8-40D1-9F75-771970233CD8Q36322305-F6B53DC1-3292-4643-B9EF-A24F6A3C113DQ37204531-71965917-DDF2-4AE2-8950-9703A3ECE755Q37315749-D6E98FC9-0021-4F42-9D10-9DBAF577D39BQ37692378-43C12026-8A6B-45D9-B179-8538CD63841DQ38379989-06156A47-48C3-4B1C-A383-B79E3CB9902AQ38397913-AFC4783D-8DFA-4A2F-988A-0025A611EE18Q38620076-0E6DFE94-4960-4137-9DC9-C2285D33A04CQ38659406-5D02937C-F1A1-4A24-AA36-14F46747D137Q38679816-FC25735D-1404-4C70-9D6A-AD5E91BB16F2Q38722132-B8774AB7-985B-4105-BFD1-219833FE0B4CQ38760200-2A07DCBD-E4EE-4C3C-84D6-9CEDA485C16EQ38813100-1D6FD664-3F90-4685-AA6E-C672B53B5DCDQ38846530-236AEA54-F337-4441-B6D5-A53A290A953EQ39067494-4BE75D4A-CBF6-4D80-8A22-70F01D3744F7Q39100607-3A7088B9-B8D4-41D6-BC9B-C39B55872B9BQ39198845-A30273B8-9BA7-48A5-A47E-6CD158B6B3D5Q39686395-AF71F830-AEE4-4BC0-8D3A-EC14ACF7EC94Q39713582-9A4F453A-7DE3-400B-B212-DB039F1A2560Q39985226-CC88B194-378C-4B03-9821-F629D25A99A3Q40361284-F5090B88-F8C6-4B3C-B5BF-1A8BC978C6C3Q40488679-FDE59FF3-D407-43E1-8FD6-C1522696A133Q40555670-3925B95C-B730-45FD-B33D-D27E0FF8F48BQ40632463-BEAE6751-7B55-49E0-A4AB-116D2E970C24Q41264898-BE2AC5DF-7DF9-4A99-8B75-E91111CAE0B0Q41392147-9BDA3E64-2D9A-4C82-9DEF-7323528F2612Q41887111-FE985BDF-FD2D-4E07-AA8A-F317346BD3BDQ42134079-61D4E4AB-D670-44D2-80FB-88571AF93F2CQ46990439-F75B5398-2EC8-4ABB-B7BA-69BACE7DE0B1Q47143902-46627232-62FE-455D-BF10-D778E73EC6E8Q47162461-08BA2290-CE02-4523-B531-080F5419E5CD
P2860
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
2015 ESC Guidelines for the ma ...... of Sudden Cardiac Death of the
@en
2015 ESC Guidelines for the ma ...... of Sudden Cardiac Death of the
@nl
type
label
2015 ESC Guidelines for the ma ...... of Sudden Cardiac Death of the
@en
2015 ESC Guidelines for the ma ...... of Sudden Cardiac Death of the
@nl
prefLabel
2015 ESC Guidelines for the ma ...... of Sudden Cardiac Death of the
@en
2015 ESC Guidelines for the ma ...... of Sudden Cardiac Death of the
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
2015 ESC Guidelines for the ma ...... d Congenital Cardiology (AEPC)
@en
P2093
Antonio Hernandez-Madrid
Carina Blomström-Lundqvist
Christian Spaulding
Dirk J Van Veldhuisen
Donna Fitzsimons
Gerhard Hindricks
Karl-Heinz Kuck
Keld Kjeldsen
P2860
P304
P3181
P356
10.1093/EUROPACE/EUV319
P407
P577
2015-08-29T00:00:00Z